Back
Accenture plc - Ordinary Shares - Class A Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
42
ACN
Accenture plc - Ordinary Shares - Class A
Last Price:
$249.15
Seasonality Move:
4.52%
Sell
25
RGC
Regencell Bioscience Holdings
Last Price:
$13.30
Seasonality Move:
33.33%
Sell
42
Accenture plc - Ordinary Shares - Class A (ACN)
is a Sell
Is Accenture plc - Ordinary Shares - Class A a Buy, Sell or Hold?
-
The current Accenture plc - Ordinary Shares - Class A [ACN] share price is $249.13. The Score for ACN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ACN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $13.12. The Score for RGC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACN Stock Price Chart
What is Accenture plc - Ordinary Shares - Class A's stock price today?
-
The Accenture plc - Ordinary Shares - Class A share price today is $249.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACN is experiencing slight buying pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $13.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.89 | Sell |
Relative Strength Index (14 RSI): | 35.48 | Sell |
Chaikin Money Flow: | 1395707 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (245.94 - 281.44) | Sell |
Bollinger Bands (100): | (271.31 - 316.13) | Sell |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.14 | Sell |
Relative Strength Index (14 RSI): | 44.93 | Sell |
Chaikin Money Flow: | 153369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.14 - 14.66) | Sell |
Bollinger Bands (100): | (0.19 - 24.67) | Buy |
ACN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 243.17 | Buy |
20-day SMA: | 259.45 | Sell |
50-day SMA: | 283.12 | Sell |
200-day SMA: | 325.33 | Sell |
8-day EMA: | 247.19 | Buy |
20-day EMA: | 257.15 | Sell |
50-day EMA: | 276.12 | Sell |
200-day EMA: | 310.67 | Sell |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.24 | Sell |
20-day SMA: | 13.73 | Sell |
50-day SMA: | 19.2 | Sell |
200-day SMA: | 6.31 | Buy |
8-day EMA: | 13.28 | Sell |
20-day EMA: | 14.12 | Sell |
50-day EMA: | 15.17 | Sell |
200-day EMA: | 8.86 | Buy |
Accenture plc - Ordinary Shares - Class A Earnings Growth & ACN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.04 per share, an increase this year of $0.97 per share, and an increase next year of $0.95 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Accenture plc - Ordinary Shares - Class A Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |